This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

J.C. Penney March Comp Sales Come in Stronger Than Expected

J.C. Penney (JCP - Get Report) said same-store sales in its department stores and drugstores rose in March, and the company indicated that it expects to beat the consensus earnings projections for the first quarter.

The company's same department store sales for March rose 2.7% from the year-ago period. Wall Street was expecting a 1% gain. Total department store sales for the month increased 1.3% to $1.21 billion, from just above $1.19 billion in the same period last year.

Shares of J.C. Penney, which is based in Plano, Texas, gained 77 cents, or 4.7%, to $17.20 in recent New York Stock Exchange trading.

Drugstore sales, on a comparable-store basis, rose 8.4%, with a 13.4% increase in pharmacy sales. Total drugstore sales rose 1.6% to $1.31 billion, up from $1.29 billion last year. Catalog sales fell 10.4% in the month.

J.C. Penney also said it now expects first-quarter earnings to meet, or be slightly above, the high-end of the analysts' range of 2 cents to 11 cents a share, as compiled by Thomson Financial/First Call. The consensus estimate stands at 7 cents a share.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
JCP $8.73 2.11%
AAPL $126.00 -0.35%
FB $87.55 0.30%
GOOG $522.86 -0.10%
TSLA $279.72 -0.11%

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs